Interleukin-17: Could it be a key player in COVID-19 infection severity?

Serum levels of tumor necrosis factor alpha and interferon alpha in COVID-19 patients and their correlations with disease severity.

The role of laboratory markers as predictors of severity in Covid 19 patients

Evaluation of peripheral lymphocyte subsets' alteration and IL6 serum level correlated with Severity and outcome in Corona virus disease 2019 (COVID-19)

Inflammatory Biomarkers as Prognostic and Predictive Factor in Patients with COVID-19

Potential Diagnostic and Prognostic Values of Hematological Biomarkers in COVID-19‎ ‎

C-reactive protein as an early marker of severity and outcome in patients with SARS-CoV-2 infection

The predictive value of laboratory biomarkers in defining COVID-19 severity

Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity

sIL-2R and sIL-2R/lymphocyte ratio as indicators of severity in COVID-19 pediatric patients